Skip to main content
Terug
ORINY logo

Orion Oyj

Datakwaliteit: 100%
ORINY
OTC Healthcare Drug Manufacturers - General
€ 41,04
€ 0,00 (0,00%)
Marktkapitalisatie: 23,09B
Ook genoteerd als ORINF OTC
Dagbereik
€ 38,70 € 41,04
52-Weeksbereik
€ 25,95 € 42,75
Volume
7
50D / 200D Gem.
€ 39,70 / € 38,02
Vorige Slotkoers
€ 41,04

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E 48,1 0,4
P/B 18,0 2,9
ROE % 42,0 3,8
Net Margin % 25,4 3,9
Rev Growth 5Y % 16,1 10,0
D/E 0,2 0,2

Belangrijkste Punten

Revenue grew 16,07% annually over 5 years — strong growth
Earnings grew 45,67% over the past year
ROE of 41,98% indicates high profitability
Net margin of 25,43% shows strong profitability
Debt/Equity of 0,24 — conservative balance sheet
Generating 219,20M in free cash flow

Groei

Revenue Growth (5Y)
16,07%
Revenue (1Y)22,50%
Earnings (1Y)45,67%
FCF Growth (3Y)898,18%

Kwaliteit

Return on Equity
41,98%
ROIC29,80%
Net Margin25,43%
Op. Margin33,43%

Veiligheid

Debt / Equity
0,24
Current Ratio2,40
Interest Coverage75,58

Waardering

P/E Ratio
48,05
P/B Ratio17,98
EV/EBITDA36,79
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 22,50% Revenue Growth (3Y) 26,02%
Earnings Growth (1Y) 45,67% Earnings Growth (3Y) 48,88%
Revenue Growth (5Y) 16,07% Earnings Growth (5Y) 25,49%
Profitability
Revenue (TTM) 1,89B Net Income (TTM) 480,55M
ROE 41,98% ROA 23,91%
Gross Margin 64,20% Operating Margin 33,43%
Net Margin 25,43% Free Cash Flow (TTM) 219,20M
ROIC 29,80% FCF Growth (3Y) 898,18%
Safety
Debt / Equity 0,24 Current Ratio 2,40
Interest Coverage 75,58 Dividend Yield 0,01%
Valuation
P/E Ratio 48,05 P/B Ratio 17,98
P/S Ratio 12,22 PEG Ratio -1,35
EV/EBITDA 36,79 Dividend Yield 0,01%
Market Cap 23,09B Enterprise Value 23,24B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,89B 1,54B 1,19B 1,34B 1,04B
Net Income 480,55M 329,90M 216,80M 349,50M 193,80M
EPS (Diluted) 0,86 1,18 0,77 1,25 0,69
Gross Profit 1,21B 946,40M 657,80M 849,00M 593,50M
Operating Income 631,60M 416,60M 274,90M 439,60M 243,30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,01B 1,63B 1,44B 1,50B 1,11B
Total Liabilities 725,40M 624,10M 548,50M 595,50M 366,10M
Shareholders' Equity 1,28B 1,01B 890,10M 908,10M 747,90M
Total Debt 305,27M 327,30M 200,10M 214,00M 108,50M
Cash & Equivalents 160,90M 205,60M 106,70M 332,60M 216,70M
Current Assets 1,34B 1,02B 825,30M 878,60M 690,20M
Current Liabilities 560,30M 273,40M 264,80M 275,50M 209,20M

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Growth Investing (Philip Fisher)
#102 of 154
46

Recente Activiteit

Ingestapt Growth Investing (Philip Fisher)
Mar 24, 2026